It lowers the risk of health problems.
A recent study suggests that drinking a few cups of coffee each day may provide protective benefits against heart disease, stroke, and type 2 diabetes. The research indicates that consuming around three cups of coffee daily, equating to roughly 200 to 300 milligrams of caffeine, can significantly reduce the risk of heart-related and metabolic health issues. This finding highlights the potential advantages of moderate coffee or caffeine consumption as part of a balanced diet for individuals without preexisting health conditions.
The study, conducted by Dr. Chaofu Ke from Suzhou Medical College in China, analyzed data from more than 500,000 participants in the U.K. Biobank research project. The researchers concentrated on two key groups: over 172,000 individuals who tracked their caffeine intake and around 188,000 who reported their coffee or tea consumption. By comparing these groups’ caffeine intake with their likelihood of developing cardiometabolic conditions, such as diabetes, high cholesterol, high blood pressure, and obesity, the team sought to understand the potential health impacts of caffeine consumption.
The findings revealed that any level of coffee or caffeine consumption was associated with a decreased risk of developing heart and metabolic issues. However, the greatest benefit was observed in those who consumed moderate amounts. Specifically, individuals who drank three cups of coffee per day had a 48% lower chance of developing heart or metabolic diseases than those who abstained from coffee. Similarly, those who consumed 200 to 300 milligrams of caffeine daily showed a 41% lower risk compared to those with minimal or no caffeine intake.
These results emphasize the importance of mitigating the risk of heart and metabolic diseases, as these conditions often lead to severe health outcomes. According to the study, people with these diseases are four to seven times more likely to face premature death and are also at increased risk for disability and mental health challenges. The study was published in the Journal of Clinical Endocrinology & Metabolism on September 17.
Discussion about this post